[ACRX] QoQ Quarter Result on 31-Dec-2015 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
07-Mar-2016
Financial Year
2015
Quarter
31-Dec-2015 [#Q4]
Profit Trend
QoQ- -308.05%
YoY- 23.68%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
Revenue 3,366 4,531 3,025 1,730 15,428 1,924 181 598.19%
PBT -11,438 -11,092 -10,979 -10,558 5,841 -8,896 -10,026 9.15%
Tax -36 -2,083 2 -12 772 777 806 -
NP -11,402 -11,092 -10,981 -10,546 5,069 -8,896 -10,026 8.92%
Tax Rate - - - - -13.22% - - -
Total Cost 14,768 15,623 14,006 12,276 10,359 10,820 10,207 27.83%
Ratio Analysis
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
NP Margin -338.74 -244.80 -363.01 -609.60 32.86 -462.37 -5,539.23 -84.39%
Per Share
30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 CAGR
EPS -5.03 -4.90 -4.85 -4.66 2.20 -4.01 -4.57 6.58%
EPS Diluted -5.03 -4.90 -4.85 -4.66 2.20 -4.01 -4.51 7.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.